Safety and effectiveness of long-acting versus intermediate-acting insulin for patients with type 1 diabetes: protocol for a systematic review and individual patient data network meta-analysis

INTRODUCTION: The choice of a basal insulin regimen to manage type 1 diabetes mellitus (T1DM) may have different risks of adverse events and effectiveness, due to the difference in the effectiveness of these agents across patient characteristics (eg, baseline glycosylated haemoglobin; A1(C)). Curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Veroniki, Areti Angeliki, Straus, Sharon E, Ashoor, Huda M, Hamid, Jemila S, Yu, Catherine, Tricco, Andrea C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710824/
https://www.ncbi.nlm.nih.gov/pubmed/26719325
http://dx.doi.org/10.1136/bmjopen-2015-010160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710824/
https://www.ncbi.nlm.nih.gov/pubmed/26719325
http://dx.doi.org/10.1136/bmjopen-2015-010160

Ejemplares similares